Verification evidence is still being completed.
Gelatex Technologies
Tallinn, Estonia
- Verified lead
- Märt-Erik Martens
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Management Board Member
- 2026 technical specialization
- Nanofibrous Materials, 3D Cell Culture, Tissue Engineering, and Contract Material Development
- Review cycle
- May 2026
- Full address
- Mahtra 30a, 13811 Tallinn, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Estonian e-Business Register record confirming a current public representative for Gelatex Technologies OÜ.
- Editorial note
- Gelatex is published as an Estonia biotech materials node because the official registry provides a current management-board representative while the company site fixes the Tallinn operation and its 3D cell culture and tissue-engineering focus.
Nanofibrous Materials, 3D Cell Culture, Tissue Engineering, and Contract Material Development
Business Registry ID 14145430, VAT EE101952345, Biomedical materials manufacturing and development platform
Gelatex is published as an Estonia biotech materials node because the official registry provides a current management-board representative while the company site fixes the Tallinn operation and its 3D cell culture and tissue-engineering focus.
Gelatex Technologies runs 3d cell culture materials, tissue engineering materials, and contract development and manufacturing in Tallinn, Estonia.
- Lead
- Märt-Erik Martens (verified ↗)
- Address
- Mahtra 30a, 13811 Tallinn, Estonia (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- High-throughput nanofibrous materials production
- Capabilities
- 3D Cell Culture Materials · Tissue Engineering Materials · Contract Development and Manufacturing
- Founded
- 2016
- Headcount
- 11-50
- Company page (open ↗)
Märt-Erik Martens
Management Board Member
High-throughput nanofibrous materials production
Tallinn, Estonia. Nanofibrous Materials, 3D Cell Culture, Tissue Engineering, and Contract Material Development. Review completed on 21 Mar 2026.
Estonian business registry and internal product-development quality controls
Business Registry ID 14145430, VAT EE101952345, Biomedical materials manufacturing and development platform
Nanofibrous Materials, 3D Cell Culture, Tissue Engineering, and Contract Material Development
Gelatex is published as an Estonia biotech materials node because the official registry provides a current management-board representative while the company site fixes the Tallinn operation and its 3D cell culture and tissue-engineering focus.
Gelatex is published as an Estonia biotech materials node because the official registry provides a current management-board representative while the company site fixes the Tallinn operation and its 3D cell culture and tissue-engineering focus.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Gelatex Technologies located?
- Gelatex Technologies operates from Mahtra 30a, 13811 Tallinn, Estonia, Tallinn, Estonia.
- Who runs Gelatex Technologies?
- Gelatex Technologies is led by Märt-Erik Martens, Management Board Member. Verified 21 Mar 2026.
- What does Gelatex Technologies do?
- Gelatex Technologies runs 3d cell culture materials, tissue engineering materials, and contract development and manufacturing in Tallinn, Estonia. Core capabilities: 3D Cell Culture Materials, Tissue Engineering Materials, Contract Development and Manufacturing.
Related technical briefs
Briefs that name Tallinn as a covered market or city.
